Outcomes. The second part of Table 4 displays the treatment effects of XTJYF and placebo on the nine SCL factors and sleep quality score. The results indicate that, in comparison to placebo, the XTJYF group experienced statistically significant improvement after treatment in five of the nine SCL factors, somatization (P = 0.003), obsessive-compulsive behavior (P = 0.036), depression (P = 0.001), anxiety (P < 0.001), and hostility The original data was obtained from Jin et al. [42] . We recalculated the original data from "mean (sd)" to "mean (95% CI)" in order to make these data comparable. • The original data was obtained from Derogatis [41] . We recalculated the original data from "mean (sd)" to "mean (95% CI)" in order to make these data comparable. * Compared to the Chinese and American norms, P < 0.05. Compared to the American norms, P < 0.05. Table 4 : XTJYF treatment effect on primary and secondary outcomes. (1) Statistical analysis was done using intent-to-treat analysis (ITT) with SPSS. (2) Cohen's d effect size measure, in which an effect size of 0.2 to 0.3 is considered a "small" effect, around 0.5, a "medium" effect, and 0.8 to infinity, a "large" effect, is used here. (3) The P values come from the two sample t-tests.